Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Tendonitis
ADR ID BADD_A04249
ADR Hierarchy
12      Injury, poisoning and procedural complications
12.01      Injuries NEC
12.01.07      Muscle, tendon and ligament injuries
12.01.07.007      Tendonitis
15      Musculoskeletal and connective tissue disorders
15.07      Tendon, ligament and cartilage disorders
15.07.01      Tendon disorders
15.07.01.003      Tendonitis
Description Clinical syndrome describing overuse tendon injuries characterized by a combination of PAIN, diffuse or localized swelling, and impaired performance. | A disorder of TENDONS characterized by COLLAGEN degeneration, other changes to tenocytes and the EXTRACELLULAR MATRIX, and a lack of inflammatory cells. It is caused by aging, MICROTRAUMA, or vascular compromise. Tendinosis is not a clinical diagnosis and can be confirmed only by histopathological findings. | Inflammation of TENDONS. It is characterized by the degeneration of tendons accompanied by an inflammatory repair response, fibroblastic proliferation, and formation of granulation tissue. Tendinitis is not a clinical diagnosis and can be confirmed only by histopathological findings. [MeSH]
MedDRA Code 10043255
MeSH ID D052256
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Achilles bursitis or tendinitis | Achilles tendinitis | Achilles tendonitis | Painful arc syndrome | Patellar tendinitis | Pes anserinus tendinitis or bursitis | Supinator tendonitis | Tendinitis | Tendonitis | Tendonitis exacerbated | Tibialis tendinitis | Sesamoiditis | Jumper's knee | Iliopsoas syndrome | Pes anserinus tendinitis | Calcific tendinitis | Calcific tendonitis | Elbow tendinitis | Posterior tibial tendonitis | Peroneal tendonitis | Suprapatellar tendonitis | Cervical tendonitis | Spinal tendonitis | Tendinopathy | Tendinopathies | Tendonopathy | Tendonopathies | Tendinosis | Tendinoses | Tendonosis | Tendonoses | Tendinitides | Tendonitides
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00967Fosinopril--
BADD_D00981Gabapentin--
BADD_D01022Gliclazide--
BADD_D01086Hydrocortisone0.000046%
BADD_D01167Interferon alfa-2b--
BADD_D01213Isotretinoin0.002547%
BADD_D01217Itraconazole0.006681%
BADD_D01252Leflunomide0.001071%
BADD_D01257Letrozole0.001633%
BADD_D01266Levobetaxolol hydrochloride--
BADD_D01275Levofloxacin0.004065%
BADD_D01281Levonorgestrel0.004491%
BADD_D01285Levothyroxine0.000027%
BADD_D01309Lomefloxacin--
BADD_D01310Lomefloxacin hydrochloride--
BADD_D01322Losartan0.000020%
BADD_D01418Methotrexate--
BADD_D01433Methylprednisolone0.000048%
BADD_D01449Metronidazole0.000066%
BADD_D01496Montelukast0.000032%
BADD_D01501Moxifloxacin--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01533Naproxen--
BADD_D01564Nicotine0.000627%
BADD_D01567Nilotinib0.000168%
BADD_D01576Nitrofurantoin--
BADD_D01579Nitroglycerin0.000065%
BADD_D01587Norfloxacin--
BADD_D01598Ofloxacin0.000250%
BADD_D01624Orlistat--
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages